Non-opioid Analgesics Market

Uncategorised

Non-opioid Analgesics Market Market Overview

Non-opioid Analgesics Market was valued at USD 27.5 Billion in 2022 and is projected to reach USD 39.2 Billion by 2030, growing at a CAGR of 4.8% from 2024 to 2030.

Market Size and Opportunity Analysis for Global Non-opioid Analgesics Market

The global non-opioid analgesics market has witnessed substantial growth, with its market value reaching approximately USD 40 billion in 2023. This growth is driven by an increasing prevalence of chronic pain conditions and a rising awareness about the adverse effects associated with opioid use. Non-opioid analgesics, including acetaminophen, NSAIDs, and COX-2 inhibitors, have become a preferred choice due to their safety profile and efficacy in managing pain without the risk of addiction. The market’s expansion is further supported by advancements in drug formulations and a growing emphasis on pain management strategies that prioritize patient safety and minimize dependency risks.

Looking ahead, the global non-opioid analgesics market is poised for continued growth, with an expected value surpassing USD 55 billion by 2028. Key opportunities lie in the development of novel non-opioid analgesic drugs and therapies that cater to specific pain management needs. Additionally, the increasing adoption of these medications in emerging markets and the rise in geriatric populations are likely to drive market expansion. The trend towards personalized medicine and advancements in biotechnology are also anticipated to contribute significantly to the market’s growth, presenting lucrative opportunities for stakeholders in the non-opioid analgesics sector.

Get an In-Depth Research Analysis of the Global Non-opioid Analgesics Market Size And Forecast [2024-2031]

Who are the largest Global manufacturers in the Non-opioid Analgesics Market?

By Product Type

  • Aspirin
  • Acetaminophen (Paracetamol)
  • Ibuprofen
  • Naproxen
  • Diclofenac
  • Other NSAIDs

By Route of Administration

  • Oral
  • Topical
  • Injectable
  • Transdermal

By Application

  • Pain Management
  • Fever Reduction
  • Anti-inflammatory Applications
  • Post-operative Pain Relief

By End-user

  • Hospitals
  • Clinics
  • Home Healthcare
  • Pharmacies

By Distribution Channel

  • Direct Sales
  • Retail Pharmacies
  • Online Pharmacies
  • Hospital Pharmacies

By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.

Get Discount On The Purchase of the Global Non-opioid Analgesics Market Size And Forecast [2024-2031]

Segmentation of Non-opioid Analgesics Market-

  • AbbVie Inc
  • Pfizer
  • Inc
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.
  • Centrexion Therapeutics
  • Cara Therapeutics
  • Medropharm GmbH.
  • Which regions are leading the Global Non-opioid Analgesics Market?

    • Global (United States, Global and Mexico)
    • Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
    • Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
    • South America (Brazil, Argentina, Columbia, etc.)
    • Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

    For More Information or Query, Visit @ Non-opioid Analgesics Market Research Analysis

    Detailed TOC of Global Non-opioid Analgesics Market Research Report, 2024-2031

    1. Introduction of the Global Non-opioid Analgesics Market

    • Overview of the Market
    • Scope of Report
    • Assumptions

    2. Executive Summary

    3. Research Methodology of Verified Market Research

    • Data Mining
    • Validation
    • Primary Interviews
    • List of Data Sources

    4. Global Non-opioid Analgesics Market Outlook

    • Overview
    • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
    • Porters Five Force Model
    • Value Chain Analysis

    5. Global Non-opioid Analgesics Market, By Type

    6. Global Non-opioid Analgesics Market, By Application

    7. Global Non-opioid Analgesics Market, By Geography

    • Global
    • Europe
    • Asia Pacific
    • Rest of the World

    8. Global Non-opioid Analgesics Market Competitive Landscape

    • Overview
    • Company Market Ranking
    • Key Development Strategies

    9. Company Profiles

    10. Appendix

    About Us: Verified Market Reports

    Verified Market Reports is a leading Global Research and Consulting firm servicing over 5000+ global clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.

    Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.

    Contact us:

    Mr. Edwyne Fernandes

    US: +1 (650)-781-4080

    US Toll-Free: +1 (800)-782-1768

    Website: https://www.verifiedmarketreports.com/